CCM
TTOO

Cadence Capital Management’s T2 Biosystems, Inc TTOO Stock Holding History

Cadence Capital Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-5
Closed -$418K – 680
2015
Q1 		$418K Buy
5
+1
+25% +$92.8K 0.03% 525
2014
Q4 		$409K Buy
+4
New +$330K 0.02% 529

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HCS
Harvest Capital Strategies San Francisco, California $73.7M AUM 7.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cadence Capital Management's TTOO Position: Q2 2015 in Review

Cadence Capital Management sold out of T2 Biosystems, Inc (TTOO) in Q2 2015, closing a stake of 5 shares — an estimated $418K sold.

Cadence Capital Management first reported a position in TTOO in Q4 2014 and held it in 2 quarters. The position peaked at $418K in Q1 2015. 47 funds tracked by Wall St. Rank hold TTOO as of Q2 2015.

  • Cadence Capital Management reported no remaining T2 Biosystems, Inc position as of Q2 2015 after selling out during the quarter.
  • Cadence Capital Management sold 5 T2 Biosystems, Inc shares in Q2 2015, an estimated $418K.
  • Cadence Capital Management first reported a position in T2 Biosystems, Inc in Q4 2014 and held it in 2 quarters.
  • Cadence Capital Management's T2 Biosystems, Inc position peaked at $418K in Q1 2015.
  • 47 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2015.

Based on Cadence Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.